Rhabdomyolysis due to probable interaction between simvastatin and ritonavir

被引：49

作者：

Cheng, CH

Miller, C

Lowe, C

Pearson, VE

机构：

[1] Sinai Hosp, Dept Pharm Serv, Baltimore, MD 21215 USA

[2] Johns Hopkins Univ Hosp, Dept Pharm, Baltimore, MD 21287 USA

来源：

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2002年 / 59卷 / 08期

关键词：

D O I：

10.1093/ajhp/59.8.728

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：728 / 730

页数：3

共 7 条

[1] Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: Are the statins mechanistically similar? [J].

Christians, U ;

Jacobsen, W ;

Floren, LC .

PHARMACOLOGY & THERAPEUTICS, 1998, 80 (01) :1-34

[2]

FICHTENBAUM C, 2000, 7 C RETR OPP INF SAN

[3]

Herman RJ, 1999, CAN MED ASSOC J, V161, P1281

[4]

MARTIN CM, 2000, 40 INT C ANT AG CHEM

[5] A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS [J].

NARANJO, CA ;

BUSTO, U ;

SELLERS, EM ;

SANDOR, P ;

RUIZ, I ;

ROBERTS, EA ;

JANECEK, E ;

DOMECQ, C ;

GREENBLATT, DJ .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :239-245

[6] Safety and efficacy of HMG-CoA reductase inhibitors for treatment of hyperlipidemia in patients with HIV infection [J].

Penzak, SR ;

Chuck, SK ;

Stajich, GV .

PHARMACOTHERAPY, 2000, 20 (09) :1066-1071

[7] Fatal rhabdomyolysis associated with simvastatin in a renal transplant patient [J].

Weise, WJ ;

Possidente, CJ .

AMERICAN JOURNAL OF MEDICINE, 2000, 108 (04) :351-352

← 1 →